# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA883799 | F | Antitumor activity against human bladder carcinoma 5637 cells. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
2. | ALA618432 | F | Antitumor activity against human bladder carcinoma 5637 cells | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
3. | ALA623594 | F | Antitumor activity against human renal adenocarcinoma ACHN cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
4. | ALA621833 | F | Antitumor activity against human renal adenocarcinoma ACHN cells. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
5. | ALA654817 | F | Antitumor activity against CD+ human acute T-lymphoblastic leukemia C8166 cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
6. | ALA654818 | F | Antitumor activity against CD4+ human acute T-lymphoblastic C8166 leukemia cells. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
7. | ALA656067 | F | Concentration required to reduce proliferation of CD4+ human acuteT-lymphoblastic leukemia (CCRF-CEM) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
8. | ALA652487 | F | Antitumor activity against human acute T-lymphoblastic CCRF-CEM leukemia cells. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
9. | ALA652488 | F | Antitumor activity against human acute T-lymphoblastic leukemia CCRF-CEM cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
10. | ALA651471 | F | Concentration required to reduce proliferation of human acute B-lymphoblastic (CCRF-SB) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
11. | ALA651472 | F | Antitumor activity against human acute B-lymphoblastic CCRF-SB leukemia cells. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
12. | ALA651473 | F | Antitumor activity against human acute B-lymphoblastic leukemia CCRF-SB cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
13. | ALA658289 | F | Concentration required to reduce proliferation of human foreskin fibroblasts (CRL7065) cell line by 50% as determined by the MTT method | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
14. | ALA653613 | F | Antitumor activity against human foreskin fibroblasts CRL7065 cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
15. | ALA668067 | F | Concentration required to reduce proliferation of human prostate carcinoma (DU-145) cell line by 50% as determined by the MTT method | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
16. | ALA669288 | F | Antitumor activity against human prostate carcinoma DU145 cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
17. | ALA679419 | F | Antitumor activity against human skin melanoma G361 cells. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
18. | ALA679421 | F | Antitumor activity against human skin melanoma G-361 cells | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
19. | ALA693868 | F | Antitumor activity against human colon adenocarcinoma HT-29 cells. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
20. | ALA693869 | F | Antitumor activity against human colon adenocarcinoma HT-29 cells | Homo sapiens | 4 | cell-based format | Scientific Literature |